We are monitoring the impact of COVID-19 on Latin America Cancer Immunotherapy Market Get in touch with us for detailed analysis Know More
Share on

Latin America Cancer Immunotherapy Market Research Report – Segmented By Application, Product Type, Mode Of Administration, End Users, Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1340
Pages: 132

Latin American Cancer Immunotherapy Market Size (2022 to 2027)

The Latin America Cancer Immunotherapy Market size is estimated to grow from USD 13.23 Billion in 2022 to USD 23.42 Billion by the end of 2027, growing at a CAGR of 12.10% from 2022 to 2027.

Immunotherapy is a type of treatment option that helps your immune system fight against cancer. According to the World Health Organization report, in 2018, 9.6 million people have cancer. Also, 1 out of 6 deaths is due to cancer globally. Usually, the immune system helps the body fight against infections and other diseases.  Cancer immunotherapy helps prevent the growth of cancer cells, inhibiting the cancer cells from spreading across the body. It helps the immune system to fight better against cancer cells.

The key drivers influencing the growth of the Latin America Cancer immunotherapy market are increasing cancer, changing lifestyle, Smoking and excessive alcohol intake, high efficacy of immunotherapy compared to other treatments, fewer side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer.

Various cancers such as Melanoma show resistance towards chemotherapy and radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology are the significant factors limiting the market's growth.

This research report on the Latin American Cancer Immunotherapy market has been segmented & sub-segmented into the following categories:

By Type of Therapies: 

  • Immune System Modulators
  • Immune Checkpoint Inhibitors
  • Monoclonal Antibodies

By Area of Therapy: 

  • Blood Cancer
  • Prostate Cancer
  • Melanoma
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Other Minor Areas

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the Brazilian cancer immunotherapy market holds the highest shares of the Latin American market from the past few years and is to continue the same growth rate in the forecast period. Increasing incidences of chronic diseases such as cancer are a significant factor for the market to grow. On-going research and development activities are escalating the demand of the market. Brazil has its healthcare system for cancer treatment in 2017, i.e., Brazil's National health system. They developed cancer Care policies in favor of ordinary people.

Mexican cancer immunotherapy market is positioned second in leading dominant shares of the market. Growing support from government organizations and a rise in the number of people who have cancer are likely to propel the market's demand. 

KEY MARKET PLAYERS:

Notable companies operating in the Latin American cancer immunotherapy Market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co. and Celgene Corp and Immunomedics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Breast       

                                5.1.3 Lung          

                                5.1.4 Melanoma              

                                5.1.5 Colorectal

                                5.1.6 Head & Neck          

                                5.1.7 Prostate   

                                5.1.8 Others      

                                5.1.9 Y-o-Y Growth Analysis, By Application         

                                5.1.10 Market Attractiveness Analysis, By Application     

                                5.1.11 Market Share Analysis, By Application      

                5.2 Product Type                             

                                5.2.1 Introduction           

                                5.2.2 Monoclonal Antibodies     

                                5.2.3 Checkpoint inhibitors/immune modulators              

                                5.2.4 Therapeutic cancer vaccines            

                                5.2.5 Oncolytic virus immunotherapy     

                                5.2.6 Cytokines

                                5.2.7 Adoptive T cell transfer     

                                5.2.8 Adjuvant Immunotherapy

                                5.2.9 Interferons             

                                5.2.10 Interleukins         

                                5.2.11 BCG         

                                5.2.12 Others   

                                5.2.13 Y-o-Y Growth Analysis, By Product Type   

                                5.2.14 Market Attractiveness Analysis, By Product Type

                                5.2.15 Market Share Analysis, By Product Type  

                5.3 Mode of Administration                        

                                5.3.1 Introduction           

                                5.3.2 Intravenous           

                                5.3.3 Oral            

                                5.3.4 Topical      

                                5.3.5 Intra Vesical           

                                5.3.6 Y-o-Y Growth Analysis, By Mode of Administration

                                5.3.7 Market Attractiveness Analysis, By Mode of Administration              

                                5.3.8 Market Share Analysis, By Mode of Administration

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Y-o-Y Growth Analysis, By End users            

                                5.3.5 Market Attractiveness Analysis, By End users           

                                5.3.6 Market Share Analysis, By End users            

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Product Type

                                                6.1.3.4 By Mode of Administration

                                                6.1.3.5 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Product Type

                                                6.1.4.4 By Mode of Administration

                                                6.1.4.5 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Product Type

                                                6.1.5.4 By Mode of Administration

                                                6.1.5.6 By End users

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche Ltd                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen                         

                8.3 Viralytics                      

                8.4 Novartis Pharmaceuticals Corporation                            

                8.5 Pfizer                            

                8.6 GlaxoSmithKline Pharmaceuticals Limited                     

                8.7 AstraZeneca plc                        

                8.8 Medivation                

                8.9 Advaxis                        

                8.10 Bristol-Myers Squibb                           

                8.11 Merck & Co. and Celgene Corp                        

                8.12 Immunomedics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Cancer Immunotherapy Market By Application, From 2022 - 2027 (USD Million)
  2. Latin America Breast Market By Region, From 2022 - 2027 (USD Million)
  3. Latin America Lung Market By Region, From 2022 - 2027 (USD Million)
  4. Latin America Melanoma Market By Region, From 2022 - 2027 (USD Million)
  5. Latin America Colorectal Market By Region, From 2022 - 2027 (USD Million)
  6. Latin America Head & Neck Market By Region, From 2022 - 2027 (USD Million)
  7. Latin America Prostate Market By Region, From 2022 - 2027 (USD Million)
  8. Latin America Cancer Immunotherapy Market By Product Type, From 2022 - 2027 (USD Million)
  9. Latin America Monoclonal Antibodies Market By Region, From 2022 - 2027 (USD Million)
  10. Latin America Checkpoint inhibitors/immune modulators Market By Region, From 2022 - 2027 (USD Million)
  11. Latin America Therapeutic cancer vaccines Market By Region, From 2022 - 2027 (USD Million)
  12. Latin America Oncolytic virus immunotherapy Market By Region, From 2022 - 2027 (USD Million)
  13. Latin America Cytokines Market By Region, From 2022 - 2027 (USD Million)
  14. Latin America Adoptive T cell Transfer Market By Region, From 2022 - 2027 (USD Million)
  15. Latin America Adjuvant immunotherapy Market By Region, From 2022 - 2027 (USD Million)
  16. Latin America Interferons Market By Region, From 2022 - 2027 (USD Million)
  17. Latin America Interleukins Market By Region, From 2022 - 2027 (USD Million)
  18. Latin America BCG Market By Region, From 2022 - 2027 (USD Million)
  19. Latin America Cancer Immunotherapy Market By Mode of Administration, From 2022 - 2027 (USD Million)
  20. Latin America Intravenous Market By Region, From 2022 - 2027 (USD Million)
  21. Latin America Oral Market By Region, From 2022 - 2027 (USD Million)
  22. Latin America Topical Market By Region, From 2022 - 2027 (USD Million)
  23. Latin America Intravesical Market By Region, From 2022 - 2027 (USD Million)
  24. Latin America Cancer Immunotherapy Market By End users, From 2022 - 2027 (USD Million)
  25. Latin America hospitals Market By Region, From 2022 - 2027 (USD Million)
  26. Latin America Clinics Market By Region, From 2022 - 2027 (USD Million)
  27. Brazil Cancer Immunotherapy Market By Application, From 2022 - 2027 (USD Million)
  28. Brazil Cancer Immunotherapy Market By Product Type, From 2022 - 2027 (USD Million)
  29. Brazil Cancer Immunotherapy Market By Mode of Administration, From 2022 - 2027 (USD Million)
  30. Brazil Cancer Immunotherapy Market By End users, From 2022 - 2027 (USD Million)
  31. Argentina Cancer Immunotherapy Market By Application, From 2022 - 2027 (USD Million)
  32. Argentina Cancer Immunotherapy Market By Product Type, From 2022 - 2027 (USD Million)
  33. Argentina Cancer Immunotherapy Market By Mode of Administration, From 2022 - 2027 (USD Million)
  34. Argentina Cancer Immunotherapy Market By End users, From 2022 - 2027 (USD Million)
  35. Mexico Cancer Immunotherapy Market By Application, From 2022 - 2027 (USD Million)
  36. Mexico Cancer Immunotherapy Market By Product Type, From 2022 - 2027 (USD Million)
  37. Mexico Cancer Immunotherapy Market By Mode of Administration, From 2022 - 2027 (USD Million)
  38. Mexico Cancer Immunotherapy Market By End users, From 2022 - 2027 (USD Million)
  39. Rest of Latin America Cancer Immunotherapy Market By Application, From 2022 - 2027 (USD Million)
  40. Rest of Latin America Cancer Immunotherapy Market By Product Type, From 2022 - 2027 (USD Million)
  41. Rest of Latin America Cancer Immunotherapy Market By Mode of Administration, From 2022 - 2027 (USD Million)
  42. Rest of Latin America Cancer Immunotherapy Market By End users, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample